PPIB Unveiled: A Comprehensive Pan-Cancer Exploration Unraveling Immunological Signatures and Prognostic Implications
Authors:
- Yan OuyangYOYan Ouyang
- Qi DaiQDQi Dai
- Shengming LaiSLShengming Lai
- Haiyan HuangHHHaiyan Huang
- Yongsheng HuangYHYongsheng Huang
- Shuwei RenSRShuwei Ren
Open Access
- 22 February 2024
- journal article
- research article
- Published by Global Journals in Global Journal of Medical Research
- Vol. 24 (F1) , 1-12
Abstract
Background Peptidylprolyl isomerase B PPIB has been shown to play an essential role in tumor initiation and progression However it lacks systematic analysis and evaluation of the effect of PPIB on pan-cancer Methods The expression profile and survival analysis of PPIB in tumor tissues were demonstrated by the TIMER2 0 GEPIA2 0 and UALCAN online tools The cBioportal GSCA TISDB and TIMER2 0 databases were applied to analyze the correlation between PPIB and genetic variation immune infiltration and cancer-associated fibroblasts CAFs respectively The STRING GEPIA2 0 and TIMER2 0 databases were used to identify the co-expressed genes of PPIB The DAVID online database was used for GO and KEGG pathway analysis Results PPIB was highly expressed in 20 types of tumors Upregulation of PPIB was associated with a poor prognosis of 6 types of tumors P 0 05 In most cancers the frequency of PPIB genetic variation is relatively low and the common mutation types are missense mutations and splicesKeywords
This publication has 33 references indexed in Scilit:
- The ever‐increasing importance of cancer as a leading cause of premature death worldwideCancer, 2021
- Methylation multiplicity and its clinical values in cancerExpert Reviews in Molecular Medicine, 2021
- Memory CD8+ T cell responses to cancerSeminars in Immunology, 2020
- Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymeraseNature, 2019
- In search of definitions: Cancer‐associated fibroblasts and their markersInternational Journal of Cancer, 2019
- Cyclophilin B induces chemoresistance by degrading wild‐type p53 via interaction with MDM2 in colorectal cancerThe Journal of Pathology, 2018
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia, 2017
- Hallmarks of Cancer: The Next GenerationCell, 2011
- DNA Methylation and Cancer2010
- The cancer genomeNature, 2009